Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

115.67
Delayed Data
As of Jan 13
 +3.30 / +2.94%
Today’s Change
67.81
Today|||52-Week Range
132.95
+2.65%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close112.37
Today’s open112.87
Day’s range112.22 - 115.73
Volume371,449
Average volume (3 months)499,211
Market cap$5.0B
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+33.18%
Earnings growth (next 5 years)+25.50%
Revenue growth (last year)+43.09%
P/E ratio119.2
Price/Sales12.92
Price/Book13.36

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...-0.14-0.16%
MASIMasimo Corp+0.23+0.32%
NUVANuVasive Inc+0.46+0.66%
CMDCantel Medical Corp+0.67+0.87%
Data as of 4:02pm ET, 01/13/2017

Financials

Next reporting dateJanuary 26, 2017
EPS forecast (this quarter)$0.29
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts


Search for Jobs